Chemoinformaics analysis of Hexadeca methyl cyclo octasiloxane
| Molecular Weight | 593.24 | nRot | 0 |
| Heavy Atom Molecular Weight | 544.856 | nRig | 16 |
| Exact Molecular Weight | 592.15 | nRing | 1 |
| Solubility: LogS | -8.274 | nHRing | 1 |
| Solubility: LogP | 7.362 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 109.382 |
| nHD | 0 | BPOL | 185.562 |
| QED | 0.329 |
| Synth | 4.484 |
| Natural Product Likeliness | 0.012 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.952 |
| HIA | 0.995 |
| CACO-2 | -6.222 |
| MDCK | 0.000105232 |
| BBB | 0 |
| PPB | 1.18052 |
| VDSS | 4.091 |
| FU | 0.435216 |
| CYP1A2-inh | 0.169 |
| CYP1A2-sub | 0.969 |
| CYP2c19-inh | 0.866 |
| CYP2c19-sub | 0.968 |
| CYP2c9-inh | 0.882 |
| CYP2c9-sub | 0.982 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.942 |
| CYP3a4-inh | 0.54 |
| CYP3a4-sub | 0.049 |
| CL | 2.557 |
| T12 | 0.1 |
| hERG | 0.459 |
| Ames | 0.026 |
| ROA | 0 |
| SkinSen | 0.949 |
| Carcinogencity | 0.021 |
| EI | 0.996 |
| Respiratory | 0.022 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.732915 |